Literature DB >> 15607230

Advanced genetic strategies for recombinant protein expression in Escherichia coli.

Hans Peter Sørensen1, Kim Kusk Mortensen.   

Abstract

Preparations enriched by a specific protein are rarely easily obtained from natural host cells. Hence, recombinant protein production is frequently the sole applicable procedure. The ribosomal machinery, located in the cytoplasm is an outstanding catalyst of recombinant protein biosynthesis. Escherichia coli facilitates protein expression by its relative simplicity, its inexpensive and fast high-density cultivation, the well-known genetics and the large number of compatible tools available for biotechnology. Especially the variety of available plasmids, recombinant fusion partners and mutant strains have advanced the possibilities with E. coli. Although often simple for soluble proteins, major obstacles are encountered in the expression of many heterologous proteins and proteins lacking relevant interaction partners in the E. coli cytoplasm. Here we review the current most important strategies for recombinant expression in E. coli. Issues addressed include expression systems in general, selection of host strain, mRNA stability, codon bias, inclusion body formation and prevention, fusion protein technology and site-specific proteolysis, compartment directed secretion and finally co-overexpression technology. The macromolecular background for a variety of obstacles and genetic state-of-the-art solutions are presented.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15607230     DOI: 10.1016/j.jbiotec.2004.08.004

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  206 in total

1.  High growth rate downregulates fumA mRNA transcription but is dramatically compensated by its mRNA stability in Escherichia coli.

Authors:  Hsiao-Hsien Lin; Ching-Hsueh Lin; Shiaw-Min Hwang; Ching-Ping Tseng
Journal:  Curr Microbiol       Date:  2012-05       Impact factor: 2.188

Review 2.  Structures of membrane proteins.

Authors:  Kutti R Vinothkumar; Richard Henderson
Journal:  Q Rev Biophys       Date:  2010-02       Impact factor: 5.318

3.  Characterization of a nitric oxide synthase from the plant kingdom: NO generation from the green alga Ostreococcus tauri is light irradiance and growth phase dependent.

Authors:  Noelia Foresi; Natalia Correa-Aragunde; Gustavo Parisi; Gonzalo Caló; Graciela Salerno; Lorenzo Lamattina
Journal:  Plant Cell       Date:  2010-11-30       Impact factor: 11.277

4.  Two distinct states of Escherichia coli cells that overexpress recombinant heterogeneous β-galactosidase.

Authors:  Yun Zhao; Wei He; Wei-Feng Liu; Chun-Chun Liu; Li-Kui Feng; Lei Sun; Yong-Bin Yan; Hai-Ying Hang
Journal:  J Biol Chem       Date:  2012-02-02       Impact factor: 5.157

5.  Materiomics for Oral Disease Diagnostics and Personal Health Monitoring: Designer Biomaterials for the Next Generation Biomarkers.

Authors:  Wenjun Zhang; Ming L Wang; Sammy Khalili; Steven W Cranford
Journal:  OMICS       Date:  2016-01

6.  Disulfide bond formation and activation of Escherichia coli β-galactosidase under oxidizing conditions.

Authors:  Joaquin Seras-Franzoso; Roman Affentranger; Mario Ferrer-Navarro; Xavier Daura; Antonio Villaverde; Elena García-Fruitós
Journal:  Appl Environ Microbiol       Date:  2012-01-27       Impact factor: 4.792

7.  Restrained expression, a method to overproduce toxic membrane proteins by exploiting operator-repressor interactions.

Authors:  Anoop Narayanan; Marc Ridilla; Dinesh A Yernool
Journal:  Protein Sci       Date:  2011-01       Impact factor: 6.725

8.  Inhibition of translation by consecutive rare leucine codons in E. coli: absence of effect of varying mRNA stability.

Authors:  Ping Shu; Huacheng Dai; Wenwu Gao; Emanuel Goldman
Journal:  Gene Expr       Date:  2006

Review 9.  Current state and recent advances in biopharmaceutical production in Escherichia coli, yeasts and mammalian cells.

Authors:  Aleš Berlec; Borut Strukelj
Journal:  J Ind Microbiol Biotechnol       Date:  2013-02-06       Impact factor: 3.346

10.  Escherichia coli allows efficient modular incorporation of newly isolated quinomycin biosynthetic enzyme into echinomycin biosynthetic pathway for rational design and synthesis of potent antibiotic unnatural natural product.

Authors:  Kenji Watanabe; Kinya Hotta; Mino Nakaya; Alex P Praseuth; Clay C C Wang; Daiki Inada; Kosaku Takahashi; Eri Fukushi; Hiroki Oguri; Hideaki Oikawa
Journal:  J Am Chem Soc       Date:  2009-07-08       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.